Diagnostics & Research
The Diagnostics & Research industry has a total of 48 stocks, with a combined market cap of $690.7 billion, total revenue of $169.45 billion and a weighted average PE ratio of 39.62.
Market Cap
690.7B
Revenue
169.45B
Profits
17.43B
PE Ratio
39.62
Profit Margin
10.29%
Dividend Yield
0.24%
48 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 183.03B | 1.09% | 4,184,252 | 45.20B |
| 2 | DHR | Danaher Corporation | 129.29B | 1.13% | 6,993,143 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.45B | -0.79% | 1,417,130 | 4.45B |
| 4 | A | Agilent Technologies, Inc. | 38.25B | 0.11% | 4,989,450 | 7.23B |
| 5 | WAT | Waters Corporation | 37.66B | 4.61% | 3,019,771 | 3.77B |
| 6 | NTRA | Natera, Inc. | 31.99B | 4.41% | 2,690,790 | 2.50B |
| 7 | IQV | IQVIA Holdings Inc. | 30.41B | 0.62% | 2,597,487 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 24.66B | 2.68% | 2,567,360 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 23.86B | 1.47% | 509,209 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.57B | -0.66% | 1,264,346 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 21.32B | -0.75% | 930,448 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 17.20B | -2.65% | 3,513,756 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 12.77B | -0.23% | 288,597 | 2.68B |
| 14 | RVTY | Revvity, Inc. | 11.66B | 3.29% | 2,337,799 | 2.90B |
| 15 | ICLR | ICON Public Limited Company | 10.42B | -0.53% | 1,581,287 | 8.25B |
| 16 | CRL | Charles River Laboratories International, Inc. | 8.70B | -0.35% | 1,040,992 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 7.57B | -0.14% | 3,045,184 | 2.10B |
| 18 | BLLN | BillionToOne, Inc. | 4.55B | 1.22% | 405,823 | 354.54M |
| 19 | SHC | Sotera Health Company | 4.46B | -0.70% | 2,678,066 | 1.19B |
| 20 | RDNT | RadNet, Inc. | 4.37B | 0.40% | 589,208 | 2.14B |
| 21 | TWST | Twist Bioscience Corporation | 4.16B | -3.13% | 2,132,712 | 409.48M |
| 22 | VCYT | Veracyte, Inc. | 3.70B | -3.44% | 1,232,840 | 541.74M |
| 23 | GRAL | GRAIL, Inc. | 3.08B | -3.03% | 1,247,696 | 156.12M |
| 24 | ADPT | Adaptive Biotechnologies Corporation | 2.42B | -0.26% | 2,293,281 | 295.41M |
| 25 | WGS | GeneDx Holdings Corp. | 1.54B | 3.67% | 1,143,434 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.37B | 3.24% | 1,939,935 | 745.97M |
| 27 | PSNL | Personalis, Inc. | 1.19B | 3.83% | 4,471,484 | 64.52M |
| 28 | CDNA | CareDx, Inc. | 1.18B | 0.53% | 685,259 | 412.82M |
| 29 | OPK | OPKO Health, Inc. | 1.10B | 2.10% | 2,890,052 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 639.36M | -4.66% | 358,632 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 515.19M | -0.55% | 1,185,265 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 374.96M | -5.92% | 6,042,062 | 829.00M |
| 33 | PRE | Prenetics Global Limited | 355.08M | 4.56% | 378,994 | 92.39M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 200.51M | -4.90% | 238,150 | 1.95M |
| 35 | BDSX | Biodesix, Inc. | 164.97M | 2.06% | 106,769 | 96.10M |
| 36 | FONR | FONAR Corporation | 125.14M | - | 336,762 | 105.34M |
| 37 | XGN | Exagen Inc. | 120.32M | -1.97% | 352,858 | 68.38M |
| 38 | BNR | Burning Rock Biotech Limited | 98.29M | -7.72% | 36,428 | 77.14M |
| 39 | PRPO | Precipio, Inc. | 40.69M | -2.31% | 30,334 | 25.83M |
| 40 | MDXH | MDxHealth SA | 39.03M | 0.78% | 490,187 | 110.97M |
| 41 | QUCY | Quantum Cyber N.V. | 32.04M | -14.09% | 4,081,987 | 537.08K |
| 42 | MBAI | Check-Cap Ltd. | 11.66M | -7.47% | 102,917 | - |
| 43 | XWEL | XWELL, Inc. | 10.56M | -6.02% | 175,826 | 28.83M |
| 44 | NOTV | Inotiv, Inc. | 9.98M | 1.06% | 536,726 | 507.36M |
| 45 | ADVB | Advanced Biomed Inc. | 8.28M | 28.13% | 286,852 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 7.51M | 1.21% | 87,541 | 5.66M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 6.82M | -0.36% | 9,835 | - |
| 48 | ISPC | iSpecimen Inc. | 4.54M | -4.82% | 142,924 | 1.03M |